Order Article Reprints

Rugo HS, Xu B, Dasgupta A, Kaushik A, Verret W, Singh B. A Meta-Analysis of Patient-Reported Outcomes of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Previously Treated HR+/HER− mBC Using Two Phase 3 (TROPiCS-02 and EVER-132-002) Trials. Cancers. 2025; 17(11):1885. https://doi.org/10.3390/cancers17111885

Rugo, Hope S., Binghe Xu, Anandaroop Dasgupta, Ankita Kaushik, Wendy Verret, and Barinder Singh. 2025. "A Meta-Analysis of Patient-Reported Outcomes of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Previously Treated HR+/HER− mBC Using Two Phase 3 (TROPiCS-02 and EVER-132-002) Trials" Cancers 17, no. 11: 1885. https://doi.org/10.3390/cancers17111885

Rugo, H. S., Xu, B., Dasgupta, A., Kaushik, A., Verret, W., & Singh, B. (2025). A Meta-Analysis of Patient-Reported Outcomes of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Previously Treated HR+/HER− mBC Using Two Phase 3 (TROPiCS-02 and EVER-132-002) Trials. Cancers, 17(11), 1885. https://doi.org/10.3390/cancers17111885